UnknownNot applicableNCT06007235

CACIPLIQ20 in Wound Healing in Subjects With Epidermolysis Bullosa

Studying Dystrophic epidermolysis bullosa

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Organ, Tissue, Regeneration, Repair and Replacement
Principal Investigator
Christine Bodemer, MD, PhD
Hopital Necker - enfants malades
Intervention
CACIPLIQ20(device)
Enrollment
16 enrolled
Eligibility
3-18 years · All sexes
Timeline
2024 – 2024

Study locations (1)

Collaborators

Euraxi Pharma · ARANZ Medical

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06007235 on ClinicalTrials.gov

Other trials for Dystrophic epidermolysis bullosa

Additional recruiting or active studies for the same condition.

See all trials for Dystrophic epidermolysis bullosa →

← Back to all trials